As evidence has mounted that new diabetes and weight loss drugs can provide ... Eli Lilly, after tirzepatide's late-stage cardio win, plots regulatory filings this year As for Alzheimer’s ...

The second day of the conference saw several big pharma players plot their strategic roadmaps ... after reporting a disappointing sales preview for its blockbuster weight-loss therapy tirzepatide. In ...

Gastrointestinal adverse events partially mediated the weight loss effects among patients with obesity who received tirzepatide vs placebo.

On the basis of the clinical trial data, patients on Zepbound (tirzepatide) 5mg weekly lost 16.1 kg (35.5 lb) on average after 72 weeks. For Zepbound’s 10mg weekly dose, the average weight loss ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Physician–scientists at the University of Utah's John A. Moran Eye Center have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide ...

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the main ingredient in its popular weight-loss medicine Zepbound.

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding demand has caused many to wonder if they are indeed the magical solution ...

Enter GetSimpli Oral Tirzepatide, a revolutionary product that promises to transform your approach to weight loss and metabolic health. Unlike traditional weight loss methods that often involve ...

Katie Price is not letting up on her desire for more surgery as she addressed her recent extreme weight loss, which has caused concern among her fans. The 46-year-old former glamour model showed ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Compared to placebo, the data showed that: Tirzepatide resulted in weight loss of nearly 18% after 72 weeks. Semaglutide produced nearly 14% weight loss after 68 weeks. Retatrutide generated ...